Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma-Reference-Cited by-同舟云学术

Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma

Published:2021-06-03 Issue:11 Volume:13 Page:15164-15192
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Maimaiti Aierpati¹,Wang Xixian¹,Pei Yinan¹,Nuermaimaiti Nuerbiye²,Tuersunniyazi Abudireheman¹,Abula Yaeraili¹,Feng Zhaohai¹,Jiang Lei¹,Shi Xin¹,Kasimu Maimaitijiang¹

Affiliation:

1. Department of Functional Neurosurgery, Neurosurgery Centre, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830054, China

2. State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Disease in Central Asia, Department of Biochemistry and Molecular Biology, Basic Medicine College, Xinjiang Medical University, Urumqi, Xinjiang 830054, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Ageing

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel disulfidptosis-related lncRNA signature predicts prognosis and therapeutic response in low-grade glioma;2023-10-30

2. A TGF‐β signaling‐related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response;CNS Neuroscience & Therapeutics;2023-10-18

3. Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma;Frontiers in Genetics;2023-07-04

4. Foreboding lncRNA markers of low-grade gliomas dependent on metabolism;Medicine;2022-11-04

5. LncRNA as potential biomarker and therapeutic target in glioma;Molecular Biology Reports;2022-11-04